Blog

Leveraging Real world evidence (RWE) & Outcomes for Minority Groups in Successful Trial Research

As the impressive pace of Covid-19 vaccinations continues in the U.S. with the goal of bringing the pandemic to an end, disparities in vaccine rollouts and hesitancy continue to affect racial minority Americans. As of mid May 2021, only 15% of Hispanic Americans and 16% of Black Americans were fully vaccinated against Covid-19, compared to […]

Take Patients Off Mute: Placing Patients at the Core of Clinical Initiatives Through Linguistic Validation

The world of translations is evolving, and translations for clinical trials are no exception. Technology keeps evolving, enabling companies to incorporate machine translation into their processes. Recent advances include incorporation of Natural Language Processing (NPL) and transformer-based machine learning techniques such as Google’s new Bidirectional Encoder Representations from Transformers (BERT) algorithm, which can consider the […]

Why Linguistic Validation is Crucial To Ensuring eCOA is Culturally and Conceptually Equivalent

Over the last 20 years, the worldwide number of clinical trials has increased exponentially. Clinical trials also become more complex, with the adoption of multi-center, international interventions becoming the norm. This means that the pharmaceutical industry is confronted with the exponential growth in costs associated with running such clinical trials, with each molecule requiring approximately […]

Driving Diversity in Clinical Trials

A recent article published by Clinical Leader illustrates the importance of making information about clinical trial participation accessible to those who are currently under-represented in pharmaceutical research. The findings concluded that understanding where minority groups are currently going to find further information is a good start to bridging the existing disparities in Clinical Research by […]